These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26314506)

  • 41. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants.
    Chaki S; Ago Y; Palucha-Paniewiera A; Matrisciano F; Pilc A
    Neuropharmacology; 2013 Mar; 66():40-52. PubMed ID: 22640631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.
    Saragoussi D; Chollet J; Bineau S; Chalem Y; Milea D
    Int J Clin Pract; 2012 Nov; 66(11):1079-87. PubMed ID: 23067031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression.
    Rhein C; Reichel M; Kramer M; Rotter A; Lenz B; Mühle C; Gulbins E; Kornhuber J
    J Affect Disord; 2017 Feb; 209():10-15. PubMed ID: 27866044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
    Fakhoury M
    Mol Neurobiol; 2016 Jul; 53(5):2778-2786. PubMed ID: 25823514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment.
    Lai IC; Hong CJ; Tsai SJ
    Neuropsychobiology; 2003; 48(4):182-5. PubMed ID: 14673215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
    Mamdani F; Berlim MT; Beaulieu MM; Labbe A; Merette C; Turecki G
    Transl Psychiatry; 2011 Jun; 1(6):e13. PubMed ID: 22832429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG; Reece CE; Sawyer AC; Johnson S; Lawrence D; Zubrick SR
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):177-184. PubMed ID: 27154239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder.
    He S; Zhang T; Hong B; Peng D; Su H; Lin Z; Fang Y; Jiang K; Liu X; Li H
    Neurosci Lett; 2014 Sep; 579():168-72. PubMed ID: 25079902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Keeping up with the clinical advances: depression.
    Ragguett RM; Tamura JK; McIntyre RS
    CNS Spectr; 2019 Aug; 24(S1):25-37. PubMed ID: 31248466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.
    Parsey RV; Oquendo MA; Ogden RT; Olvet DM; Simpson N; Huang YY; Van Heertum RL; Arango V; Mann JJ
    Biol Psychiatry; 2006 Jan; 59(2):106-13. PubMed ID: 16154547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients.
    Mouri A; Ikeda M; Koseki T; Iwata N; Nabeshima T
    Neurosci Lett; 2016 Mar; 617():22-6. PubMed ID: 26845564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.
    Lopez JP; Fiori LM; Cruceanu C; Lin R; Labonte B; Cates HM; Heller EA; Vialou V; Ku SM; Gerald C; Han MH; Foster J; Frey BN; Soares CN; Müller DJ; Farzan F; Leri F; MacQueen GM; Feilotter H; Tyryshkin K; Evans KR; Giacobbe P; Blier P; Lam RW; Milev R; Parikh SV; Rotzinger S; Strother SC; Lewis CM; Aitchison KJ; Wittenberg GM; Mechawar N; Nestler EJ; Uher R; Kennedy SH; Turecki G
    Nat Commun; 2017 May; 8():15497. PubMed ID: 28530238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
    Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
    Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New approaches to the pharmacological management of major depressive disorder.
    Witkin JM; Li X
    Adv Pharmacol; 2009; 57():347-79. PubMed ID: 20230766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. mRNA Expression of
    Rhein C; Zoicas I; Marx LM; Zeitler S; Hepp T; von Zimmermann C; Mühle C; Richter-Schmidinger T; Lenz B; Erim Y; Reichel M; Gulbins E; Kornhuber J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram.
    Svenningsson P; Berg L; Matthews D; Ionescu DF; Richards EM; Niciu MJ; Malinger A; Toups M; Manji H; Trivedi MH; Zarate CA; Greengard P
    Mol Psychiatry; 2014 Sep; 19(9):962-4. PubMed ID: 24614495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.
    Feyissa AM; Woolverton WL; Miguel-Hidalgo JJ; Wang Z; Kyle PB; Hasler G; Stockmeier CA; Iyo AH; Karolewicz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):279-83. PubMed ID: 19945495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response.
    Lopez JP; Kos A; Turecki G
    Curr Opin Psychiatry; 2018 Jan; 31(1):7-16. PubMed ID: 29076893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.